CUPCOMP: A multi-site UK trial in carcinoma of unknown primary: A comparison across tissue and liquid biomarkers. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This abstract ...
Hologic's shares rise after receiving FDA clearance and CE mark for its rapid molecular GI assays on the Panther Fusion platform.
The oncology-based molecular diagnostics market is being propelled by the increasing prevalence of cancer worldwide and the ...
The fully automated PCR-based testing system will be used in microbiology and virology labs to aid the detection of viral and bacterial causes of infectious diseases.
Molecular HIV cluster detection has improved identification of rapid transmission and care gaps since 2016, enhancing HIV prevention efforts. Health departments use the Enhanced HIV/AIDS Reporting ...
(Nasdaq: HOLX) announced today that the U.S. Food and Drug Administration (FDA) has granted 510 (k) clearance for the Panther ...
The Xpert MTB/Ultra molecular diagnostic test for stool samples, until now recommended only for children, could be established as an additional test for diagnosing tuberculosis in adults living with ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback